Corticosteroids glandular fever

To minimize the risk of glucocorticoid-induced bone loss, should use the smallest possible effective dosage and duration and use topical and inhaled preparations whenever possible. Obtain baseline measurement of bone mineral density (BMD) at the lumbar spine and/or hip when initiating long-term (., exceeding 6 months) glucocorticoid therapy and initiate appropriate preventive therapy. May repeat longitudinal measurements as often as every 6 months to detect possible bone loss. Less frequent (., annually) follow-up probably is sufficient in patients who are receiving therapy to prevent bone loss.

Corticosteroids glandular fever

corticosteroids glandular fever

Media:

corticosteroids glandular fevercorticosteroids glandular fevercorticosteroids glandular fevercorticosteroids glandular fevercorticosteroids glandular fever

http://buy-steroids.org